CRISPR Therapeutics AG - 8-K Filing
CRISPR Therapeutics appoints Andrew J. Silver as CFO and discloses financial statements (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 9.01 Financial Statements and Exhibits)
Tickers: $CRSP